AKT1 and cancer: Hence, our finding provided further evidence to demonstrate the putative role for Cdh1 as a tumor suppressor [24] and indicated that reduced expression of Cdh1 in certain types of human cancers [13] might be a biomarker to predict the elevation of PI3K/Akt activities.